Therapy of Malignant Hamster Insulinomas with Monoamine Precursors

Overview

Journal Diabetologia

Specialty Endocrinology

Date 1981 Feb 1

PMID 6259010

Authors

J M Feldman

C Vervaert

C Klatt

H F Seigler

Affiliations

Soon will be listed here.

References

Cegrell L . The occurrence of biogenic monoamines in the mammalian endocrine pancreas. Acta Physiol Scand Suppl. 1968; 314:1-60. View

Scott D, Fisher A . THE INSULIN AND THE ZINC CONTENT OF NORMAL AND DIABETIC PANCREAS. J Clin Invest. 1938; 17(6):725-8. PMC: 434829. DOI: 10.1172/JCI101000. View

Wilson J, Downs Jr R, Feldman J, Lebovitz H . Beta cell monoamines: further evidence for their role in modulating insulin secretion. Am J Physiol. 1974; 227(2):305-12. DOI: 10.1152/ajplegacy.1974.227.2.305. View

Cunningham G, QUICKEL K, Lebovitz H . The use of insulin dynamics in the evaluation of streptozotocin therapy of malignant insulinomas. J Clin Endocrinol Metab. 1971; 33(3):530-6. DOI: 10.1210/jcem-33-3-530. View

GRUNT J, Pallotta J, Soeldner J . Blood sugar, serum insulin and free fatty acid interrelationships during intravenous tolbutamide testing in normal young adults and in patients with insulinoma. Diabetes. 1970; 19(2):122-6. DOI: 10.2337/diab.19.2.122. View

Shapiro S, Kaneko Y, Baum S, Fleischer N . The role of calcium in insulin release from hamster insulinoma cells. Endocrinology. 1977; 101(2):485-93. DOI: 10.1210/endo-101-2-485. View

Shen S . Disordered glucose and insulin metabolism in patients with insulinoma. Arch Intern Med. 1975; 135(5):668-72. View

Cegrell L . Dopamine in a human islet cell carcinoma metastasis. Acta Pathol Microbiol Scand A. 1970; 78(6):734. DOI: 10.1111/j.1699-0463.1970.tb03526.x. View

Lins P, Efendic S . Responses of patients with insulinomas to stimulators and inhibitors of insulin release that have been linked with cyclic adenosine monophosphate. Diabetes. 1979; 28(3):190-5. DOI: 10.2337/diab.28.3.190. View

10.

Scandellari C, Zaccaria M, De Palo C, Sicolo N, Erle G, Federspil G . The effect of propranolol on hypoglycaemia. Observations in five insulinoma patients. Diabetologia. 1978; 15(4):297-301. DOI: 10.1007/BF02573822. View

11.

Lebovitz H, Feldman J . Pancreatic biogenic amines and insulin secretion in health and disease. Fed Proc. 1973; 32(7):1797-802. View

12.

Wurtman R, Axelrod J . A SENSITIVE AND SPECIFIC ASSAY FOR THE ESTIMATION OF MONOAMINE OXIDASE. Biochem Pharmacol. 1963; 12:1439-41. DOI: 10.1016/0006-2952(63)90215-6. View

13.

Dayan A . Absence of catecholamines from islet cells of human pancreas and a beta-cell tumour in man. Acta Histochem. 1967; 28(1):186-9. View

14.

Lees A, Shaw K, Kohout L, STERN G, Elsworth J, Sandler M . Deprenyl in Parkinson's disease. Lancet. 1977; 2(8042):791-5. DOI: 10.1016/s0140-6736(77)90725-5. View

15.

SAIFER A, GERSTENFELD S . The photometric microdetermination of blood glucose with glucose oxidase. J Lab Clin Med. 1958; 51(3):448-60. View

16.

Henry D, Starman B, Johnson D, Williams R . A sensitive radioenzymatic assay for norepinephrine in tissues and plasma. Life Sci. 1975; 16(3):375-84. DOI: 10.1016/0024-3205(75)90258-1. View

17.

Feldman J, HENDERSON J, Blalock J . Effect of pharmacological agents and fasting on pancreatic islet norepinephrine in the golden hamster. Diabetologia. 1979; 17(3):169-74. DOI: 10.1007/BF01219745. View

18.

Coyle J, Henry D . Catecholamines in fetal and newborn rat brain. J Neurochem. 1973; 21(1):61-7. DOI: 10.1111/j.1471-4159.1973.tb04225.x. View

19.

Hales C, Randle P . Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963; 88:137-46. PMC: 1203862. DOI: 10.1042/bj0880137. View

20.

Zern R, FOSTER L, Blalock J, Feldman J . Characteristics of the dopaminergic and noradrenergic systems of the pancreatic islets. Diabetes. 1979; 28(3):185-9. DOI: 10.2337/diab.28.3.185. View